| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $16.4M | +25.7% |
| SG&A Expense | $6.0M | -15.7% |
| Operating Income | -$22.4M | -11.0% |
| Pre-tax Income | -$22.2M | -13.8% |
| Income Tax | -$2.4M | -34.3% |
| Net Income | -$19.8M | -11.7% |
| EPS (Basic) | -$2.08 | -11.2% |
| EPS (Diluted) | -$2.08 | -11.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.9M | -72.0% |
| Current Assets | $7.6M | -70.3% |
| Total Assets | $7.9M | -70.5% |
| Current Liabilities | $5.4M | +6.9% |
| Total Liabilities | $5.4M | +2.8% |
| Stockholders' Equity | $2.5M | -88.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.8M | +22.1% |
| Financing Cash Flow | -$40K | — |